DNA Methylation in Peripheral Blood: Providing Novel Biomarkers of Exposure and Immunity to Examine Cancer Risk
- 1 December 2021
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 30 (12), 2176-2178
- https://doi.org/10.1158/1055-9965.epi-21-0866
Abstract
DNA methylation is an epigenetic phenomenon that can alter and control gene expression. Because methylation plays a key role in cell differentiation, methylation markers have been identified that are unique to a given cell type; these markers are stable and can be measured in tissue or whole blood. The article by Katzke and colleagues, published in this issue, uses methylation markers to estimate proportions of immune cell subtypes in peripheral blood samples that were collected prior to diagnosis, thus allowing them to directly examine associations with pancreatic cancer risk. Given that immune-cell counts cannot be measured from archived blood, and that retrospective case–control studies rely on blood that is collected after cancer diagnosis, few studies have been able to examine the role of the systemic immune response in cancer risk. Measurement of DNA methylation in peripheral blood, primarily through development of whole-genome approaches, has also opened new doors to examining cancer etiology. See related article by Katzke et al., p. 2179This publication has 20 references indexed in Scilit:
- Smoking-associated DNA methylation markers predict lung cancer incidenceClinical Epigenetics, 2016
- DNA methylation changes measured in pre‐diagnostic peripheral blood samples are associated with smoking and lung cancer riskInternational Journal of Cancer, 2016
- Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC studyEpigenomics, 2016
- Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL)BMC Bioinformatics, 2016
- Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control studyThe Lancet Diabetes & Endocrinology, 2015
- Genome-wide analysis reveals DNA methylation markers that vary with both age and obesityGene, 2014
- F2RL3 Methylation as a Biomarker of Current and Lifetime Smoking ExposuresEnvironmental Health Perspectives, 2014
- Differential DNA Methylation in Umbilical Cord Blood of Infants Exposed to Low Levels of Arsenic in UteroEnvironmental Health Perspectives, 2013
- Blood-based profiles of DNA methylation predict the underlying distribution of cell typesEpigenetics, 2013
- Hypomethylation distinguishes genes of some human cancers from their normal counterpartsNature, 1983